PRDM9 and breast cancer: Importantly KDM6A is among the most frequently mutated genes in BC [166,167] and its frequent loss of function also reinforces the oncogenic roles of EZH2 in these BC tumors, as the EZH2 activity (as histone methyltransferase) is opposed by that of KDM6A.